Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled study of Gelsemium sempervirens for induced anticipatory anxiety in healthy volunteers
2009-011345-43Phase 4Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Gelsemium sempervirens (3 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Anxiety level before the Stroop test. Started Apr 2009; status: active.
02
Drugs
Gelsemium sempervirens
Beyond the preview
Go deeper on 2009-011345-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011345-43.